IP Verse

Laboratoire Français Du Fractionnement Et Des Biotechnologies opposition analysis

COMPANY ANALYSIS

Latest patents of Laboratoire Français Du Fractionnement Et Des Biotechnologies opposed by its competitors

Patent:
EP3481415
Grant Date:
Sep 6, 2023
Title:
Stable Liquid Fibrinogen
Oppositions:
3
Patent:
EP3806891
Grant Date:
Aug 2, 2023
Title:
Combination Of Factor Vii And An Anti-Factor Ix/X Bispecific Antibody
Oppositions:
1
Patent:
EP2651978
Grant Date:
Jan 12, 2022
Title:
Use Of An Antibody Directed Against A Membrane Protein
Oppositions:
1
Patent:
EP3390452
Grant Date:
May 26, 2021
Title:
New Use Of An Anti-Cd303 Transmembrane Protein Antibody
Oppositions:
1
Patent:
EP3277723
Grant Date:
Jun 17, 2020
Title:
Cell Line Overexpressing Human Cd303 Antigen
Oppositions:
1
Patent:
EP3116527
Grant Date:
Sep 4, 2019
Title:
Method For Preparing Human Plasma Proteins
Oppositions:
2
Patent:
EP2345425
Grant Date:
Jul 11, 2018
Title:
Immunoglobulin G (Igg) Concentrate Depleted Of Anti-A And Anti-B Antibodies And Of Polyreactive Iggs
Oppositions:
2

Competitors of Laboratoire Français Du Fractionnement Et Des Biotechnologies

CSL BEHRING GMBH

STRAWMAN LIMITED

TAKEDA PHARMACEUTICALS INTERNATIONAL AG

Want to track Laboratoire Français Du Fractionnement Et Des Biotechnologies?

Feel free to send us a message here and we will get back to you